March 13 (Reuters) - Avexis Inc:
* AVEXIS INC - GENETHON GRANTED AVEXIS LICENSE TO PATENTS IN U.S., EUROPE AND JAPAN, FOR AAV9 SMN PRODUCT
* AVEXIS - GENETHON ALSO GRANTED AVEXIS IN VIVO GENE THERAPY DELIVERY OF AAV9 VECTOR INTO CNS Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)